Mode
Text Size
Log in / Sign up

Neovascular glaucoma

Part of Glaucoma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for neovascular glaucoma

6 trials tracked for neovascular glaucoma: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 16 citations.

6Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 3 Phase 2 1 Other / NA 2
  1. Phase 3 Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients Completed · 16 cited
  2. Phase 3 Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied Completed · 15 cited
  3. Phase 3 An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. Completed
  4. Phase 2 Ahmed Glaucoma Valve Surgery With Mitomycin-C Completed
  5. N/A Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma Completed
  6. N/A Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Neovascular glaucoma: what the trials found

Aflibercept has been evaluated in Phase 3 trials for the management of neovascular glaucoma. In one study, Aflibercept administration resulted in a significant reduction in intraocular pressure (IOP) from baseline to week 1 (-8.3; p=0.0004).

In another Phase 3 trial involving Aflibercept, results for IOP change at week 1 were -8.5 and -4.9 (p=0.0644). Regarding the Neovascularization of the Iris (NVI) grade, these trials reported improvement rates of 13% and 70.4% respectively.

Ranibizumab was also evaluated in a Phase 3 trial for this condition.

Recent results — preliminary, needs further review

  • Mitomycin-C was assessed in a Phase 2 trial (not yet corroborated).
  • MicroPulse® P3 Glaucoma Device (MP3) showed Cup-to-disc Ratio (CDR) and OCT-assessed CDR of 0.82 (not yet corroborated).
  • Aflibercept was evaluated in a small study showing specific baseline and week 52 IOP measurements (not yet corroborated).

For the clinician treating this condition

  • Aflibercept is associated with significant reductions in intraocular pressure (IOP) at one week post-treatment.
  • Clinical evidence for Aflibercept shows varying rates of improvement in Neovascularization of the Iris (NVI) grade between different Phase 3 studies.
  • Ranibizumab has been investigated as a treatment option in Phase 3 clinical trials.

AI synthesis of 0 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Glaucoma

Related studies from across the Glaucoma family.

Transconjunctival bleb needling with mitomycin C reduces intraocular pressure in pediatric congenital glaucoma
Ophthalmology Sys. Review
Transconjunctival bleb needling with mitomycin C reduces intraocular pressure in pediatric congenital glaucoma New surgical technique helps manage severe glaucoma in children
This case report describes a 9-year-old patient with refractory primary congenital glaucoma. Transconjunctival bleb needling with mitomycin …
A minimally invasive procedure helped lower high eye pressure in a child with severe glaucoma and a complex surgical history.
Intraluminal stent removal from Paul glaucoma implants significantly reduces intraocular pressure in glaucoma patients
Ophthalmology Meta-analysis
Intraluminal stent removal from Paul glaucoma implants significantly reduces intraocular pressure in glaucoma patients Stent Removal Reduces Eye Pressure in Glaucoma Patients
This meta-analysis of 5 observational studies indicates that removing the intraluminal stent from a Paul glaucoma implant (PGI) significantl…
Removing a specific internal stent from a glaucoma implant can significantly lower eye pressure, especially for patients with high initial p…
Medicinal mushroom-derived compounds show potential for managing oxidative stress and inflammation in ocular conditions
Drug Pipeline Sys. Review
Medicinal mushroom-derived compounds show potential for managing oxidative stress and inflammation in ocular conditions Medicinal mushrooms show promise for several common eye conditions
This narrative review synthesizes evidence regarding medicinal mushroom-derived bioactive compounds, including polysaccharides and triterpen…
Medicinal mushrooms contain compounds that may protect the eyes from inflammation and damage, though more clinical trials are needed to conf…
Oxidative stress and reactive oxygen species mediate retinal ganglion cell death and optic nerve damage
Drug Pipeline Sys. Review
Oxidative stress and reactive oxygen species mediate retinal ganglion cell death and optic nerve damage Oxidative stress and nerve damage drive glaucoma progression
This narrative review explores the role of oxidative stress and reactive oxygen species (ROS) as key mediators of retinal ganglion cell deat…
New research identifies how oxidative stress and reactive oxygen species damage the optic nerve in people with glaucoma.
Postoperative glaucoma occurs in 25.6% of eyes following Boston Type 1 Keratoprosthesis implantation
Ophthalmology Meta-analysis
Postoperative glaucoma occurs in 25.6% of eyes following Boston Type 1 Keratoprosthesis implantation Meta-analysis tracks glaucoma risks after Boston Type 1 Keratoprosthesis
This meta-analysis of 1,482 eyes evaluates glaucoma outcomes following Boston Type 1 Keratoprosthesis (KPro) implantation. The study reports…
A meta-analysis of 1,482 eyes shows that about 25.6% of patients experience some form of glaucoma after a Boston Type 1 Keratoprosthesis pro…
Preservative Free Bimatoprost 0.01% Shows Non Inferiority to Higher Concentration Formulations
Ophthalmology Sys. Review
Preservative Free Bimatoprost 0.01% Shows Non Inferiority to Higher Concentration Formulations Preservative-free bimatoprost shows similar results for glaucoma eye pressure
Preservative-free bimatoprost 0.01% provides comparable intraocular pressure reduction to higher concentrations with improved local tolerabi…
A new look at eye drops shows that preservative-free bimatoprost lowers eye pressure as well as stronger versions with fewer side effects.
Photobiomodulation protocol aims to consolidate preclinical evidence for ophthalmic diseases
Rheumatology Meta-analysis
Photobiomodulation protocol aims to consolidate preclinical evidence for ophthalmic diseases Planning to Review Light Therapy for Common Eye Diseases and Injuries
This is a protocol for a systematic review and meta-analysis, not a completed study. It outlines plans to evaluate photobiomodulation (PBM) …
Experts are planning a large review to see if light therapy can help treat common eye problems like glaucoma and vision loss.
Portable visual-field testing devices show 86% sensitivity and 88% specificity for glaucoma diagnosis
Ophthalmology Meta-analysis
Portable visual-field testing devices show 86% sensitivity and 88% specificity for glaucoma diagnosis Portable devices show promise for diagnosing glaucoma more quickly
This meta-analysis of 2,254 participants with glaucoma and controls evaluated the diagnostic accuracy of portable visual-field testing devic…
New research suggests portable vision tests can accurately detect glaucoma while significantly cutting down the time patients spend in testi…
Glucocorticoid signaling and stress-related neuroendocrine dysregulation influence intraocular pressure and inflammatory pathways in ocular diseases
Rheumatology Sys. Review
Glucocorticoid signaling and stress-related neuroendocrine dysregulation influence intraocular pressure and inflammatory pathways in ocular diseases Stress and hormones may play a role in eye health
This narrative literature overview of 35 studies synthesizes the role of glucocorticoid signaling and stress-related neuroendocrine dysregul…
New research suggests that stress-related hormone changes could influence conditions like glaucoma and other serious eye diseases.
Unadjusted hazard ratio of 2.14 for mortality in primary open-angle glaucoma patients
Ophthalmology Meta-analysis
Unadjusted hazard ratio of 2.14 for mortality in primary open-angle glaucoma patients Understanding the link between glaucoma and overall health risks for patients
This meta-analysis evaluates the mortality risk associated with various types of glaucoma, including POAG, PACG, and congenital glaucoma. Th…
A large review shows that people with certain types of glaucoma may face higher health risks, highlighting the need for full-body care.
Glaucoma prevalence in Africa varies widely with diagnostic criteria; standardized ISGEO definitions narrow estimates
Ophthalmology Meta-analysis
Glaucoma prevalence in Africa varies widely with diagnostic criteria; standardized ISGEO definitions narrow estimates Standardized rules help track how common glaucoma is in Africa
This systematic review of 9 population-based studies in Africa found that glaucoma prevalence estimates range from 4.3% to 5.3% when using f…
Using consistent diagnostic rules for glaucoma helps doctors get a clearer picture of how many people are affected across different regions.
Surgical intervention improves refractive error and visual acuity in short eyes
Orthopedics & Sports Medicine Meta-analysis
Surgical intervention improves refractive error and visual acuity in short eyes Surgery Improves Vision Outcomes for Patients with Short Eyes
This systematic review and meta-analysis of 1,110 eyes indicates that surgical procedures significantly improve visual acuity and refractive…
New analysis shows surgical procedures can improve vision and eye measurements for patients with specific conditions like nanophthalmos and …